ITGA3 and ITGB1 form a specific type of integrin receptor (ITGA3/ITGB1), and dysregulation of ITGA3/ITGB1-mediated signaling enhances cancer cell aggressiveness in several types of cancer [32–34]. This evidence concerns the gene ITGB1 and cancer.